MedPath

The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring

Not Applicable
Completed
Conditions
Endometrium
Infertility, Female
Interventions
Procedure: UC-MSCs therapy
Registration Number
NCT03592849
Lead Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Brief Summary

The purpose of the study is to evaluate the safety and effectiveness of the collagen scaffold loaded with umbilical cord derived mesenchymal stem cells (UC-MSCs) in infetile women with thin endometrium or endometrial scarring.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
20
Inclusion Criteria
  1. Infertile patients with clear fertility desires
  2. Diagnosed with thin endometrium or endometrial scarring for whom drugs and surgical interventions were ineffective
  3. 20-42 years old
  4. Normal ovarian function or with frozen embryos
  5. Willing to actively cooperate with postoperative follow-up
Exclusion Criteria
  1. With abnormal chromosome karyotype
  2. With other uterine diseases including large intramural myomas, severe endometriosis, severe adenomyosis, severe congenital uterine malformations, endometrial tuberculosis, vaginitis and endometritis
  3. Systemic diseases: hypertension, diabetes, and so on
  4. Contraindications to pregnancy
  5. Contraindications to hormone replacement therapy
  6. Medical history of pelvic tumors or receiving pelvic radiotherapy
  7. Involved in other clinical studies
  8. Unable to adhere to the follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
UC-MSCs therapyUC-MSCs therapytransplant collagen scaffold loaded with UC-MSCs to treat infertility caused by thin endometrium or endometrial scarring
Primary Outcome Measures
NameTimeMethod
endometrial thickness12 months

endometrium thickness evaluated by transvaginal sonography during late proliferating phase

Secondary Outcome Measures
NameTimeMethod
endometrial blood flow6 months

uterine blood flow evaluated by transvaginal sonography

ongoing pregnancy rate24 months

the presence of a living intrauterine fetus on TVU at the 12th week of gestation

live birth rate24 months

a live born baby ≥28 weeks of gestation

Trial Locations

Locations (1)

Nanjing Drum Tower Hospital

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath